Avidity Biosciences, Inc.RNANASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
12.18%
↓ 46% below average
Average (26q)
22.52%
Historical baseline
Range
High:101.30%
Low:-16.02%
Volatility
520.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 12.18% |
| Q2 2025 | 38.83% |
| Q1 2025 | 4.04% |
| Q4 2024 | 23.87% |
| Q3 2024 | 20.73% |
| Q2 2024 | -4.33% |
| Q1 2024 | 26.54% |
| Q4 2023 | 10.69% |
| Q3 2023 | 11.82% |
| Q2 2023 | -10.66% |
| Q1 2023 | 4.72% |
| Q4 2022 | 22.22% |
| Q3 2022 | -6.21% |
| Q2 2022 | 43.70% |
| Q1 2022 | -16.02% |
| Q4 2021 | 32.77% |
| Q3 2021 | 9.36% |
| Q2 2021 | 9.81% |
| Q1 2021 | 51.82% |
| Q4 2020 | 44.04% |
| Q3 2020 | 5.24% |
| Q2 2020 | 62.05% |
| Q1 2020 | -1.79% |
| Q4 2019 | 10.71% |
| Q3 2019 | 101.30% |
| Q2 2019 | 100.71% |
| Q1 2019 | 0.00% |